LERCANIDIPINE TEVA 10 MG

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
30-04-2017

Bahan aktif:

LERCANIDIPINE HYDROCHLORIDE

Tersedia dari:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kode ATC:

C08CA13

Bentuk farmasi:

TABLETS

Komposisi:

LERCANIDIPINE HYDROCHLORIDE 10 MG

Rute administrasi :

PER OS

Jenis Resep:

Required

Diproduksi oleh:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Area terapi:

LERCANIDIPINE

Indikasi Terapi:

Mild to moderate essential hypertension.

Tanggal Otorisasi:

2016-09-30

Selebaran informasi

                                PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with a
doctor’s prescription only
LERCANIDIPINE TEVA
®
10 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 10 mg
LERCANIDIPINE TEVA
®
20 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 20 mg
For the list of inactive ingredients,
please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet
contains
concise
information about the medicine. If
you have further questions, refer to
the doctor or pharmacist.
This medicine has been prescribed
to treat your ailment. Do not pass it
on to others. It may harm them even
if it seems to you that their ailment
is similar.
The medicine is not intended for use
in children under 18 years of age.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
For the treatment of mild to moderate
hypertension.
THERAPEUTIC GROUP:
Calcium channel blockers of the
dihydropyridine group.
2. B E F O R E
U S I N G
T H E
MEDICINE
DO NOT USE THE MEDICINE IF:
∙ You are pregnant or breastfeeding,
think you are pregnant, are
planning a pregnancy or do not
use contraceptives.
∙ You are sensitive (allergic) to
the active ingredient or to any
of the other ingredients of the
medicine (see section 6), or to
other medicines from this group,
such as: amlodipine, nicardipine,
felodipine, isradipine, nifedipine
or lacidipine.
∙ You suffer from certain heart
diseases, such as: uncontrolled
heart failure, an obstruction
of blood flow from the heart,
unstable angina (angina at rest
or which gradually increases),
or within one month of a heart
attack.
∙ You suffer from a severe liver or
kidney disease.
∙ You are concomitantly taking:
cyclosporine,
antifungal
medicines, such as ketoconazole
or
itraconazole,
macrolide
antibiotics such as erythromycin
or troleandomycin, antiviral
medicines such as ritonavir.
∙ You consume grapefruits or
grapefruit juice.
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Arab 30-04-2017
Selebaran informasi Selebaran informasi Ibrani 08-01-2017

Peringatan pencarian terkait dengan produk ini